Heart FailureNCT07883369
Development and Evaluation of a Disease-oriented Scenario Game to Promote ACP Among Older Adults and Family Caregivers
A study testing tabletop game and ACP Exercise Book in people with Heart Failure and Older Adults (65 Years and Older), run by Taipei Veterans General Hospital, Taiwan at 1 site in Taiwan.
Trial summary
Current advance care planning (ACP) tabletop games mostly focus on exploring "personal values." While a few explore care preferences through "hypothetical scenarios," they are not disease-oriented, which can create discrepancies between the scenarios or medical treatments and the patient's actual condition and may… Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Heart Failure, Older Adults (65 Years and Older), Family Caregivers
- What is being tested?
- tabletop game and ACP Exercise Book
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 164 participants
- Where
- 1 siteTaiwan
- Study dates
- 15 Oct 2026to 31 Dec 2027
- Phase
- Interventional
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Older adults aged 65 years or older with heart failure and their family caregivers.
- Older adults with heart failure are defined as those with ICD-10 codes, and the first three digits of the older adults' ICD code must be I50.
- Family caregivers must be over 18 years of age.
Who cannot join
- Severe intellectual disability or inability to understand the research instructions or explanations provided by the researchers.
- Inability to communicate in either Mandarin or Taiwanese.
- Severe sensory or expressive impairments (e.g., visual or auditory impairments or aphasia).
- Older adults with heart failure or whose family caregivers refuse to participate.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Taiwan1 site
Taipei Veterans General Hospital
Taipei, 112
Hui-Chuan Cheng, PhD, 886-28712121 ext. 86288, cheng_hc@vghtpe.gov.tw
About this study
Official title: Development and Evaluation of a Disease-oriented Scenario Game to Promote Advance Care Planning Among Older Adults and Family Caregivers: Heart Failure as an Example (Part 2)
Current advance care planning (ACP) tabletop games mostly focus on exploring "personal values." While a few explore care preferences through "hypothetical scenarios," they are not disease-oriented, which can create discrepancies between the scenarios or medical treatments and the patient's actual condition and may fail to capture the patient's true preferences. A systematic review found that disease-oriented ACP interventions effectively capture patients' and their families' preferences for medical treatments because they closely reflect the patient's actual disease progression. However, no disease-oriented scenario games are currently available. Therefore, this study, using heart failure as an example, aims to develop and evaluate the impact of disease-oriented scenario games on older adults and family caregivers in ACP.
- Conditions
- Heart Failure, Older Adults (65 Years and Older), Family Caregivers, Life Support Treatment, Tabletop Game
- Being tested
- tabletop game, ACP Exercise Book
- Medical subject headings
- Heart Failure
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
tabletop gameBehavioural
Using tabletop games to promote consistency in medical treatment preferences between older adults with heart failure and their family caregivers.
ACP Exercise BookBehavioural
Using ACP Exercise Book
| Study group | Role | What they receive |
|---|---|---|
| Tabletop game | Experimental | participate tabletop game Receives: Behavioral: tabletop game |
| ACP Exercise Book | Active comparator | receive ACP Exercise Book Receives: Behavioral: ACP Exercise Book |
What is being measured
The primary outcome is the main question the study is designed to answer.
The Questionnaire on Life Support Preferences for Heart Failure Patients (QLSP-HF)
The questionnaire has 30 items and covers three scenarios and ten medical treatments. The scenarios include current health status, end-stage heart failure, and end-stage heart failure with loss of consciousness. The ten medical treatments assessed are antibiotics, inotropes, nasogastric tube feeding, intravenous fluids, cardiopulmonary resuscitation, ventilator support, dialysis, implantable cardioverter-defibrillators (ICDs), left ventricular assist device (LVAD), and heart transplantation. We use a 5-point Likert scale ranging from 1 (absolutely do not want) to 5 (absolutely want), yielding total scores from 30 to 150. Higher scores reflect a stronger preference for life-sustaining treatment.
Measured: Baseline, Post-intervention immediately, Post-intervention one month
Secondary outcomes (3)
advance care planning (ACP) attitudes
The attitude section includes 12 questions about participants' feelings toward implementing ACP. A 5-point Likert scale is used, with scores ranging from "strongly disagree (1 point)" to "strongly agree (5 points)". The higher the total attitude score, the more positive the attitude towards ACP.
Measured: Baseline, Post-intervention immediately, Post-intervention one month
advance care planning (ACP) behavioral intention
The behavioral intention section consists of 6 questions that concern the likelihood of implementing ACP in the future. These questions cover discussing future medical decisions with family, friends, or healthcare professionals; participating in ACP consultations; and signing advance directives (ADs). The scoring system ranges from "very unlikely (1 point)" to "very likely (5 points)". The higher the total score for behavioral intention, the more positive the behavioral intention for ACP.
Measured: Baseline, Post-intervention immediately, Post-intervention one month
State-Trait Anxiety Inventory- State Anxiety Scale (STAI-S)
STAI-S is used to measure an individual's current anxiety level. It uses a 4-point Likert scale, ranging from "almost none (1 point)" to "almost all (4 points)", with a score range of 20 to 80 points; the higher the score, the higher the level of anxiety.
Measured: Baseline, Post-intervention immediately, Post-intervention one month
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Oct 2026
- Study start15 Oct 2026 (estimated)
- Primary completion31 Dec 2027 (estimated)
- Study completion31 Dec 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Heart FailureStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 164 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Taipei Veterans General Hospital, Taiwan
- Sponsor type
- Other government
- Collaborators
- National Science and Technology Council, Taiwan
- Responsible party
- Principal investigator, Cheng, Hui- Chuan, Taipei Veterans General Hospital, Taiwan
- Investigators
- Li-Shan Ke, PhD, Principal investigator, National Taipei University of Nursing and Health Sciences
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07883369
- Sponsor's protocol ID
- 2026-09-008A
- Status last verified
- Sep 2026
- First submitted
- 30 Sep 2026
- Last updated
- 20 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No